including patients' medical records and genetic information, Seerlinq's AI algorithms aim to identify patterns and predict outcomes for better disease management. This approach is particularly focused on improving the quality of life for patients with heart failure, by offering more precise and personalized treatment options. Seerlinq operates in the biotechnology industry and is committed to reinventing PPG analysis to elevate non-invasive medical practices.